| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |